Skip to main content
. 2023 Apr 22;6:445. doi: 10.1038/s42003-023-04821-2

Fig. 3. p52 drives the invasion and proliferation of glioma cells through ETS1.

Fig. 3

a Proliferation assay plot depicts the average number of cells counted relative to 0 h (mean ± s.d) in U-87 MG and U-251 MG NFKB2 and ETS1 KD cells with and without TWEAK-induced NF-κB/p52 activation. The data shown represent n = 3 biological replicates. b Transwell invasion assay was performed in U-87 MG and U-251 MG ETS1 KD cells with and without TWEAK treatment. Representative images from n = 3 biological replicates are shown. Scale bars: 400 µm. Representative plots depict the average number of invaded cells (mean ± s.d) across five fields. Representative plots depicting the average tumour volume (mean ± s.d) of U-87 MG cells injected into mice that express either CRISPR control, NFKB2 KD or ETS1 KD and overexpression control or TWEAK c over 35 days and d on day 35. The data shown represent n = 4 mice. Two-way ANOVA was used for all statistical analyses where *P < 0.05; **P < 0.01; ***P < 0.001.